PASG Passage Bio, Inc.
Healthcare$5.22+1.26%ClosedMarket Cap: $16.8M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.43
P/S
0.00
EV/EBITDA
0.30
DCF Value
$6.70
FCF Yield
-182.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-150.9%
ROA
-103.3%
ROIC
-238.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-8.9M | $-7.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-13.8M | $-13.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-43.2M | $-45.5M | $— | — |
| Q3 null | $0.00 | NaN% | $-8.7M | $-7.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-10.3M | $-9.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-16.5M | $-15.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-14.3M | $-12.7M | $— | — |
| FY null | $0.00 | NaN% | $-70.4M | $-64.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-20.7M | $-19.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-17.4M | $-16.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-18.1M | $-16.7M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-18.4M | $-16.8M | $-6.10 | — |